Janelle Fernandes

Cooley secured the complete dismissal of a securities class action regarding Revance’s statements about US Food and Drug Administration approval prospects. The court dismissed all claims with prejudice.

Cooley secured a key win on behalf of Talphera (formerly known as AcelRx Pharmaceuticals), a Silicon Valley-based specialty pharmaceutical company focused on the development and commercialization of innovative therapies, in a securities class action lawsuit brought by investors.

Cooley partnered with the Northern California Innocence Project to secure the release of Kevin Harper Jr., who was wrongfully convicted for the death of his infant son in 2008. Harper’s wrongful conviction, which resulted in a sentence of 25 years to life, was based on medical evidence that has since been widely discredited. A recent change in California’s AB 1540 law paved the way for the Sacramento District Attorney’s Office to re-review Kevin’s case. This allowed for a petition to resentence and release Harper, ending his 13-year incarceration in late January.

Cooley successfully defended Fastly, its CEO and former CFO in a securities class action alleging that Fastly mislead investors by making positive statements about its demand and large customers, while not disclosing TikTok was a major customer, and was facing heightened regulatory scrutiny by the US government. Our motion to dismiss was granted.

Cooley secured the complete dismissal of a securities class action regarding the company’s statements about its active client growth and television advertising efforts. The court dismissed all claims with prejudice.